Cost of revenue · 2011–2025
Myriad Genetics cost of revenue
$248M−1.7% · FY2025
Myriad Genetics (MYGN) reported $248M in cost of revenue for fiscal 2025, −1.7% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $248M | −1.7% | Open → |
| FY20242024-12-31 | $252M | +6.8% | Open → |
| FY20232023-12-31 | $236M | +16.9% | Open → |
| FY20222022-12-31 | $202M | +39.1% | Open → |
| FY20172017-06-30 | $145M | +9.3% | Open → |
| FY20162016-06-30 | $133M | 0.0% | Open → |
| FY20152015-06-30 | $133M | +38.2% | Open → |
| FY20142014-06-30 | $96.1M | +49.2% | Open → |
| FY20132013-06-30 | $64.4M | +25.2% | Open → |
| FY20122012-06-30 | $51.5M | +12.7% | Open → |
| FY20112011-06-30 | $45.6M | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +12.8%
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Myriad Genetics cost of revenue |url=https://companiesranked.com/en/company/myriad-genetics/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Myriad Genetics cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/myriad-genetics/cost-of-revenueBibTeX
@misc{companiesranked-en-company-myriad-genetics-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Myriad Genetics cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/myriad-genetics/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000899923-26-000018 · February 24, 2026
{{cite web |title=Myriad Genetics cost of revenue — 10-K (0000899923-26-000018) |url=https://www.sec.gov/Archives/edgar/data/899923/000089992326000018/mygn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.